Addressing the unintentional consequences of cancer therapy with novel integrative therapeutics Journal Article


Authors: Bao, T.; Peppone, L. J.; Robinson, P.
Article Title: Addressing the unintentional consequences of cancer therapy with novel integrative therapeutics
Abstract: There are 15.5 million cancer survivors in the United States because of, in part, improvements in therapy. As a result, there will be an increased burden of long- and late-term complications of cancer care, such as metabolic alterations. These metabolic changes will include alterations in bone resorption, obesity, hypercholesterolemia, and diabetes mellitus. The majority of cancer treatment-related toxicities have focused on endocrine therapy; however, chemotherapy and supportive medications, such as steroids, contribute to the development of these disorders. Because of the chronicity of these metabolic changes and their impact on morbidity, cancer risk, and outcomes as well other negative effects, including musculoskeletal pain and vasomotor symptoms, alternative strategies must be developed. These strategies should include nonpharmacologic approaches. Here, we summarize metabolic changes secondary to cancer care and integrative approaches to help alleviate therapy-associated toxicities.
Keywords: multimodality cancer therapy; combined modality therapy; neoplasm; neoplasms; metabolism; pathology; androgen antagonists; glucocorticoid; metabolic syndrome x; osteoporosis; disease management; antiandrogen; antineoplastic agents, hormonal; hypogonadism; antineoplastic hormone agonists and antagonists; glucocorticoids; metabolic syndrome; complication; procedures; delivery of health care, integrated; integrated health care system; humans; human; metabolic encephalopathy; brain diseases, metabolic
Journal Title: American Society of Clinical Oncology Educational Book
Volume: 38
ISSN: 1548-8756
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-23
Start Page: 822
End Page: 828
Language: English
DOI: 10.1200/edbk_201411
PROVIDER: scopus
PUBMED: 30231327
DOI/URL:
Notes: Am Soc Clin Oncol Educ Book -- Export Date: 2 January 2019 -- Review -- Source: Scopus C2 - 30231327
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ting   Bao
    76 Bao